K Vignesh Babu, Cm Pavalaveelzi, V Kuzhandai Velu, Ss Yuvaraj
Biochemistry, Arunai Medical College and Hospital, Tiruvannamalai, IND.
Cureus. 2025 Feb 28;17(2):e79855. doi: 10.7759/cureus.79855. eCollection 2025 Feb.
Thyroid dysfunction and diabetes mellitus are endocrine disorders that are closely associated with insulin resistance. Thyroid dysfunction has been found to be more common in patients with diabetes compared to those without. In India, thyroid dysfunction is common among patients with diabetes, with a high prevalence found in Tamil Nadu, where subclinical hypothyroidism also contributes significantly.
This study aims to determine the prevalence and association of thyroid dysfunction among patients with type 2 diabetes mellitus.
A retrospective cross-sectional study was conducted from August 2023 to August 2024. A total of 91 patients with diabetes were screened for thyroid dysfunction. Data on demographics, comorbidities, duration of diabetes, glycated hemoglobin (HbA1c), and thyroid function (triiodothyronine, thyroxine, and thyroid-stimulating hormone) were collected. Statistical analysis was performed to identify the association among thyroid dysfunction, glycemic control, and diabetes mellitus duration.
Thyroid dysfunction was identified in 21 (23.1%) of the study population, with 19 (20.9%) patients experiencing hypothyroidism and two (2.2%) patients experiencing hyperthyroidism. The prevalence was found to be high in women. Subjects with diabetes for more than five years had a high prevalence of thyroid dysfunction. HbA1c did not show any significant correlation (p = 0.327).
This study shows the prevalence of thyroid dysfunction, especially hypothyroidism, among patients with diabetes. It also highlights the importance of screening for thyroid function in patients who have had diabetes for more than five years. Early identification and management of thyroid dysfunction may improve glycemic control and reduce the risk of long-term complications.
甲状腺功能障碍和糖尿病是与胰岛素抵抗密切相关的内分泌疾病。与无糖尿病患者相比,甲状腺功能障碍在糖尿病患者中更为常见。在印度,甲状腺功能障碍在糖尿病患者中很常见,在泰米尔纳德邦患病率很高,其中亚临床甲状腺功能减退也占很大比例。
本研究旨在确定2型糖尿病患者中甲状腺功能障碍的患病率及其相关性。
于2023年8月至2024年8月进行了一项回顾性横断面研究。共对91例糖尿病患者进行了甲状腺功能障碍筛查。收集了人口统计学、合并症、糖尿病病程、糖化血红蛋白(HbA1c)和甲状腺功能(三碘甲状腺原氨酸、甲状腺素和促甲状腺激素)的数据。进行统计分析以确定甲状腺功能障碍、血糖控制和糖尿病病程之间的关联。
研究人群中有21例(23.1%)被诊断为甲状腺功能障碍,其中19例(20.9%)为甲状腺功能减退,2例(2.2%)为甲状腺功能亢进。女性患病率较高。糖尿病病程超过五年的受试者甲状腺功能障碍患病率较高。HbA1c未显示出任何显著相关性(p = 0.327)。
本研究显示了糖尿病患者中甲状腺功能障碍,尤其是甲状腺功能减退的患病率。它还强调了对糖尿病病程超过五年的患者进行甲状腺功能筛查的重要性。早期识别和管理甲状腺功能障碍可能改善血糖控制并降低长期并发症的风险。